Zepbound, a drug that rivals Ozempic, may one day be a treatment for sleep apnea, according to results from a new study.

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said ...

At 450 pounds, Michael Hearn decided to go undergo weight-loss surgery. He traded his food addiction for a passion for ...

Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults ...

In two trials of people with sleep apnea, Zepbound reduced the number of times breathing slowed or stopped during sleep.

Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep apnea in adults with obesity, the drugmaker said ...

The Bitcoin DeFi ecosystem displayed a stellar growth in 2024, and Mark Hendrickson believes this sector is here to stay.

The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s ...

June “Mama June” Shannon’s doctor, Dr. Anna Chacon, prescribed the TLC reality TV star Ozempic injections to battle her ...

Preliminary clinical trial results showed the obesity drug tirzepatide was highly effective at treating obstructive sleep ...

The unpublished results are the latest in a string of signs weight loss drugs may treat a variety of other conditions, too.

Eli Lilly noted that tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults that have both obstructive ...